SCHEMBL28287556

SCHEMBL28287556

CCOC(=O)CCCc1cccc2c1C(=O)NC2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 3/20 0.51
▸ CYP4A11 Q02928 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.49
▸ GAA P10253 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ DRD2 P14416 1/20 0.45
▸ ALOX5 P09917 1/20 0.43
▸ GSK3B P49841 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ PTPN1 P18031 1/20 0.40
▸ IDO1 P14902 1/20 0.39
▸ TDO2 P48775 1/20 0.39
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8853641 0.85 KDM4E (0.40) CYP4F2CYP4A11ALDH1A1GAAGSK3B
SCHEMBL31474424 0.82 ALDH1A1 (0.49) ALDH1A1GAAGSK3BKDM4EHPGD
SCHEMBL8853244 0.81 KDM4E (0.43) ALDH1A1GAASMN1; SMN2GSK3BKDM4E
SCHEMBL472072 0.81 KDM4E (0.39) CYP4F2CYP4A11ALDH1A1GAAGSK3B
Bicarbonate SCHEMBL29212760 0.80 KDM4E (0.46) ALDH1A1GAAGSK3BKDM4EHPGD
SCHEMBL11576353 0.79 ALDH1A1 (0.43) ALDH1A1GAACYP1A2GSK3BKDM4E
SCHEMBL166776 0.79 ELANE (0.43) ALDH1A1GAAGSK3BKDM4EHPGD
SCHEMBL29699198 0.79 ELANE (0.43) ALDH1A1GAAGSK3BKDM4EHPGD
SCHEMBL2508510 0.78 NR1H2 (0.47) ALDH1A1GAAALOX5GSK3BKDM4E
SCHEMBL29699286 0.78 NR1H2 (0.47) ALDH1A1GAAALOX5GSK3BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109553611-A The preparation method and purposes of Rivaroxaban intermediate 齐鲁制药有限公司 2019-04-02 — — CN claimed
Send feedback